Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dick van Soolingen

Showing results (171-180 of 273) with videos related to

Pageof 28
Sort By:
Scientific Reports|December 29, 2019
Mycobacterium tuberculosis clinical isolates of the Beijing and East-African Indian lineage induce fundamentally different host responses in mice compared to H37RvBas C Mourik, Jurriaan E M de Steenwinkel, Gerjo J de Knegt, et al.
Journal of Clinical Microbiology|November 6, 2004
Characterization of ancestral Mycobacterium tuberculosis by multiple genetic markers and proposal of genotyping strategyYong-Jiang Sun, Ann S G Lee, Sze Ta Ng, et al.
Emerging Infectious Diseases|August 26, 2010
Tuberculosis acquired outside of households, rural VietnamTran N Buu, Dick van Soolingen, Mai N T Huyen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2010
The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in VietnamTran N Buu, Mai N T Huyen, Dick van Soolingen, et al.
Emerging Infectious Diseases|February 6, 2009
Nontuberculous mycobacteria, zambiaPatricia C A M Buijtels, Marianne A B van-der-Sande, Cas S de-Graaff, et al.
Journal of Clinical Microbiology|March 9, 2004
Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalences of tuberculosis and human immunodeficiency virusLydia Kivihya-Ndugga, Maarten van Cleeff, Ernest Juma, et al.
Emerging Infectious Diseases|February 6, 2009
Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strainsKristin Kremer, Marieke J van-der-Werf, Betty K Y Au, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 8, 2016
Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosisMarlanka A Zuur, Mathieu S Bolhuis, Richard Anthony, et al.
Journal of Pathogens|April 22, 2016
Nontuberculous Mycobacteria Isolated from Tuberculosis Suspects in Ibadan, NigeriaSimeon Idowu Cadmus, Bassirou Diarra, Brehima Traore, et al.
Tuberculosis (Edinburgh, Scotland)|January 27, 2015
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacyGerjo J de Knegt, Marian T ten Kate, Dick van Soolingen, et al.
Pageof 28

Showing results (171-180 of 273) with videos related to

Sort By:
Pageof 28
Scientific Reports|December 29, 2019
Mycobacterium tuberculosis clinical isolates of the Beijing and East-African Indian lineage induce fundamentally different host responses in mice compared to H37RvBas C Mourik, Jurriaan E M de Steenwinkel, Gerjo J de Knegt, et al.
Journal of Clinical Microbiology|November 6, 2004
Characterization of ancestral Mycobacterium tuberculosis by multiple genetic markers and proposal of genotyping strategyYong-Jiang Sun, Ann S G Lee, Sze Ta Ng, et al.
Emerging Infectious Diseases|August 26, 2010
Tuberculosis acquired outside of households, rural VietnamTran N Buu, Dick van Soolingen, Mai N T Huyen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2010
The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in VietnamTran N Buu, Mai N T Huyen, Dick van Soolingen, et al.
Emerging Infectious Diseases|February 6, 2009
Nontuberculous mycobacteria, zambiaPatricia C A M Buijtels, Marianne A B van-der-Sande, Cas S de-Graaff, et al.
Journal of Clinical Microbiology|March 9, 2004
Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalences of tuberculosis and human immunodeficiency virusLydia Kivihya-Ndugga, Maarten van Cleeff, Ernest Juma, et al.
Emerging Infectious Diseases|February 6, 2009
Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strainsKristin Kremer, Marieke J van-der-Werf, Betty K Y Au, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 8, 2016
Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosisMarlanka A Zuur, Mathieu S Bolhuis, Richard Anthony, et al.
Journal of Pathogens|April 22, 2016
Nontuberculous Mycobacteria Isolated from Tuberculosis Suspects in Ibadan, NigeriaSimeon Idowu Cadmus, Bassirou Diarra, Brehima Traore, et al.
Tuberculosis (Edinburgh, Scotland)|January 27, 2015
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacyGerjo J de Knegt, Marian T ten Kate, Dick van Soolingen, et al.
Pageof 28